Gland Pharma posts consolidated PAT of Rs. 273.02 crore in Q3 FY22

Gland Pharma Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 1108.994 crores during the period ended December 31, 2021 as compared to Rs. 1131.666 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 273.029 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 302.081 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 16.62 for the period ended December 31, 2021 as compared to Rs. 18.37 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 1108.994 crs	₹1131.666 crs	-2.00%
Net Profit	₹273.029 crs	₹302.081 crs	-9.62%
EPS	₹16.62	₹18.37	-9.53%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 1108.994 crores during the period ended December 31, 2021 as compared to Rs.894.549 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.273.029 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.204.107 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.16.62 for the period ended December 31, 2021 as compared to Rs.12.82 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 1108.994 crs	₹894.549 crs	23.97%
Net Profit	₹273.029 crs	₹204.107 crs	33.77%
EPS	₹16.62	₹12.82	29.64%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.3456.398 crores during the 9 Months period ended December 31, 2021 as compared to Rs.2662.690 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.925.762 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.736.554 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.56.41 for the 9 Months period ended December 31, 2021 as compared to Rs.47.10 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹3456.398 crs	₹2662.690 crs	29.81%
Net Profit	₹925.762 crs	₹736.554 crs	25.69%
EPS	₹56.41	₹47.10	19.77%

Shares of Gland Pharma Limited was last trading in BSE at Rs. 3635.00 as compared to the previous close of Rs. 3682.60. The total number of shares traded during the day was 2783 in over 1009 trades.

The stock hit an intraday high of Rs. 3689.90 and intraday low of 3610.65. The net turnover during the day was Rs. 10090165.00.

Source : Equity Bulls

Keywords

GlandPharma Q3FY22 9MFY22 ResultUpdate